# RCAN1

## Overview
RCAN1, or Regulator of Calcineurin 1, is a gene that encodes a protein involved in the regulation of calcineurin, a serine/threonine phosphatase critical for various cellular processes. The RCAN1 protein is categorized as a regulatory protein and is known for its role in modulating the calcineurin-NFAT signaling pathway, which is essential for cardiovascular function, angiogenesis, and cellular stress responses. The gene produces multiple isoforms through alternative splicing, with RCAN1.1 and RCAN1.4 being the most prominent. These isoforms have distinct functions, particularly in endothelial cells where RCAN1.4 is upregulated in response to vascular endothelial growth factor (VEGF) stimulation, influencing cell migration and vascular development (Alghanem2017RCAN1.4; Holmes2010VEGF). RCAN1's interaction with calcineurin is mediated through specific motifs, and its activity is modulated by phosphorylation, which affects its binding affinity and regulatory functions (Li2020The). The protein is ubiquitously expressed, with significant roles in both cytoplasmic and nuclear compartments, impacting gene expression and cellular homeostasis (Wang2020RCAN1).

## Structure
The RCAN1 protein, encoded by the RCAN1 gene, is characterized by multiple isoforms resulting from alternative splicing. The primary structure of RCAN1 includes several motifs crucial for its function, such as the PxIxIT, LxVP, and TxxP motifs, which are essential for its interaction with calcineurin (CN) (Li2020The). The secondary structure of RCAN1 features a core domain that undergoes a folding-upon-binding transition when interacting with CN, forming new secondary structures, including a fully populated helix and two new β strands (Li2020The). The tertiary structure of RCAN1, when bound to CN, reveals a compact conformation with a single alpha helix and two beta strands, stabilized by a hydrophobic core (Li2020The).

RCAN1's C-terminal domain is responsible for binding to CN and is intrinsically disordered, as indicated by NMR spectroscopy (Li2020The). The protein's interaction with CN is modulated by phosphorylation, which can alter its binding affinity and inhibitory function (Li2020The). The RCAN1 protein is ubiquitously expressed, with high expression levels in the adult heart and fetal brain (SerranoCandelas2014The).

## Function
The RCAN1 gene encodes a protein that plays a crucial role in regulating the calcineurin-NFAT signaling pathway, which is vital for various physiological processes, including cardiovascular function and angiogenesis (Wang2020RCAN1). RCAN1 is expressed as two major isoforms, RCAN1.1 and RCAN1.4, which have distinct roles in cellular processes. RCAN1.4 is specifically upregulated in response to VEGF stimulation in endothelial cells, facilitating VEGFR-2 internalization, cell polarity, and migration, which are essential for angiogenesis and vascular development (Alghanem2017RCAN1.4).

RCAN1.4 acts as a negative feedback inhibitor of calcineurin by binding to its catalytic domain, thereby modulating calcineurin activity and influencing endothelial cell migration and tubular morphogenesis (Holmes2010VEGF). This isoform is particularly important in the context of VEGF-A stimulation, where it is involved in endothelial cell migration and tubular morphogenesis, but not proliferation (Holmes2010VEGF). RCAN1.4's regulation of VEGFR-2 signaling is specific and does not affect other receptors, highlighting its specialized role in VEGF-mediated pathways (Alghanem2017RCAN1.4).

In healthy human cells, RCAN1 is active in both the cytoplasm and nucleus, where it influences gene expression and cellular stress responses, contributing to the maintenance of vascular health and function (Wang2020RCAN1).

## Clinical Significance
RCAN1 (regulator of calcineurin 1) is implicated in several diseases due to its altered expression levels and interactions. In hepatocellular carcinoma (HCC), RCAN1 acts as a tumor suppressor by inhibiting cell proliferation and invasion while promoting apoptosis. Overexpression of RCAN1 in HCC cells leads to increased expression of pro-apoptotic proteins and decreased expression of anti-apoptotic proteins, suggesting its potential as a therapeutic target (Yang2024Identification).

In Alzheimer's disease (AD) and Down syndrome (DS), RCAN1 is overexpressed, contributing to neuronal apoptosis through the activation of caspase pathways. This overexpression is linked to the release of cytochrome c from mitochondria, promoting neuronal death. RCAN1's role in AD is further supported by its involvement in amyloid-beta production and tau pathology, which are key features of the disease (Wong2022RCAN1; Sun2011Regulator).

RCAN1 is also associated with cardiovascular diseases, particularly atherosclerosis. Increased expression of RCAN1, especially the RCAN1.4 isoform, is observed in atherosclerotic arteries. This upregulation is linked to the accumulation of oxidized low-density lipoproteins and foam cell formation, suggesting that reducing RCAN1 expression may have protective effects against atherosclerosis (Wang2020RCAN1).

## Interactions
RCAN1 (Regulator of Calcineurin 1) is known for its interactions with calcineurin (CN), a serine/threonine phosphatase. RCAN1 inhibits CN through multiple short linear motifs (SLiMs) such as LxVP, PxIxIT, and TxxP motifs. The PxIxIT motif binding to CN induces a folding-upon-binding event, forming a stable tertiary domain. This interaction is modulated by phosphorylation at specific sites, including Thr 153 and Ser 136, which reduce RCAN1's binding affinity to CN (Li2020The). RCAN1 also interacts with CN by blocking substrate-binding sites and directly engaging the active site using pseudosubstrate motifs (Li2020The).

RCAN1's C-terminal region, including the EV-motif, is crucial for its inhibitory function, competing with NFAT for the same docking site on CN, thereby inhibiting NFAT signaling (MartínezMartínez2009The). Neddylation of RCAN1 enhances its stability and binding to CN, increasing its inhibitory effect on NFAT signaling (Noh2012Covalent).

RCAN1 also functions as an RNA-binding protein, interacting with specific RNA sequences. It binds to ANT1 mRNA, stabilizing it and affecting mitochondrial functions and apoptosis. The RNA aptamer R1SR13 can inhibit RCAN1-mediated NFAT and NF-κB signaling pathways, suggesting a regulatory role in these pathways (Yun2019Regulator).


## References


[1. (Wang2020RCAN1) Shuai Wang, Yuqing Wang, Kaixin Qiu, Jin Zhu, and Yili Wu. Rcan1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target. Molecular Medicine, December 2020. URL: http://dx.doi.org/10.1186/s10020-020-00249-0, doi:10.1186/s10020-020-00249-0. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s10020-020-00249-0)

[2. (Wong2022RCAN1) Helen Wong, Jordan M. Buck, Curtis Borski, Jessica T. Pafford, Bailey N. Keller, Ryan A. Milstead, Jessica L. Hanson, Jerry A. Stitzel, and Charles A. Hoeffer. Rcan1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of down syndrome, alzheimer’s disease, and normative aging. Journal of Neurodevelopmental Disorders, May 2022. URL: http://dx.doi.org/10.1186/s11689-022-09444-y, doi:10.1186/s11689-022-09444-y. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s11689-022-09444-y)

[3. (MartínezMartínez2009The) Sara Martínez-Martínez, Lali Genescà, Antonio Rodríguez, Alicia Raya, Eulàlia Salichs, Felipe Were, María Dolores López-Maderuelo, Juan Miguel Redondo, and Susana de la Luna. The rcan carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proceedings of the National Academy of Sciences, 106(15):6117–6122, April 2009. URL: http://dx.doi.org/10.1073/pnas.0812544106, doi:10.1073/pnas.0812544106. This article has 44 citations.](https://doi.org/10.1073/pnas.0812544106)

[4. (Yun2019Regulator) Yan Yun, Yun Zhang, Chen Zhang, Liyan Huang, Shichuan Tan, Pin Wang, Carles Vilariño-Gúell, Weihong Song, and Xiulian Sun. Regulator of calcineurin 1 is a novel rna-binding protein to regulate neuronal apoptosis. Molecular Psychiatry, 26(4):1361–1375, August 2019. URL: http://dx.doi.org/10.1038/s41380-019-0487-0, doi:10.1038/s41380-019-0487-0. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-019-0487-0)

[5. (Sun2011Regulator) Xiulian Sun, 孙秀莲, Yili Wu, 吴伊丽, Bin Chen, Zhuohua Zhang, Weihui Zhou, Yigang Tong, 童贻刚, Junying Yuan, Kun Xia, Hinrich Gronemeyer, Richard A. Flavell, Weihong Song, and 宋伟宏. Regulator of calcineurin 1 (rcan1) facilitates neuronal apoptosis through caspase-3 activation. Journal of Biological Chemistry, 286(11):9049–9062, March 2011. URL: http://dx.doi.org/10.1074/jbc.m110.177519, doi:10.1074/jbc.m110.177519. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m110.177519)

[6. (Alghanem2017RCAN1.4) Ahmad F. Alghanem, Emma L. Wilkinson, Maxine S. Emmett, Mohammad A. Aljasir, Katherine Holmes, Beverley A. Rothermel, Victoria A. Simms, Victoria L. Heath, and Michael J. Cross. Rcan1.4 regulates vegfr-2 internalisation, cell polarity and migration in human microvascular endothelial cells. Angiogenesis, 20(3):341–358, March 2017. URL: http://dx.doi.org/10.1007/s10456-017-9542-0, doi:10.1007/s10456-017-9542-0. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10456-017-9542-0)

[7. (Yang2024Identification) Ziqi Yang, Xiwei Deng, Didi Wen, Lijun Sun, Rui An, and Jian Xu. Identification of rcan1’s role in hepatocellular carcinoma using single-cell analysis. BMC Cancer, August 2024. URL: http://dx.doi.org/10.1186/s12885-024-12807-4, doi:10.1186/s12885-024-12807-4. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-024-12807-4)

[8. (Noh2012Covalent) Eun Hye Noh, Hee Sook Hwang, Hee Sun Hwang, Boram Min, Eunju Im, and Kwang Chul Chung. Covalent nedd8 conjugation increases rcan1 protein stability and potentiates its inhibitory action on calcineurin. PLoS ONE, 7(10):e48315, October 2012. URL: http://dx.doi.org/10.1371/journal.pone.0048315, doi:10.1371/journal.pone.0048315. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0048315)

[9. (Li2020The) Yang Li, Sarah R. Sheftic, Simina Grigoriu, Charles D. Schwieters, Rebecca Page, and Wolfgang Peti. The structure of the rcan1:cn complex explains the inhibition of and substrate recruitment by calcineurin. Science Advances, July 2020. URL: http://dx.doi.org/10.1126/sciadv.aba3681, doi:10.1126/sciadv.aba3681. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aba3681)

[10. (Holmes2010VEGF) Katherine Holmes, Elinor Chapman, Violaine See, and Michael J. Cross. Vegf stimulates rcan1.4 expression in endothelial cells via a pathway requiring ca2+/calcineurin and protein kinase c-δ. PLoS ONE, 5(7):e11435, July 2010. URL: http://dx.doi.org/10.1371/journal.pone.0011435, doi:10.1371/journal.pone.0011435. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0011435)

[11. (SerranoCandelas2014The) Eva Serrano-Candelas, Domènec Farré, Álvaro Aranguren-Ibáñez, Sergio Martínez-Høyer, and Mercè Pérez-Riba. The vertebrate rcan gene family: novel insights into evolution, structure and regulation. PLoS ONE, 9(1):e85539, January 2014. URL: http://dx.doi.org/10.1371/journal.pone.0085539, doi:10.1371/journal.pone.0085539. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0085539)